About Kenvue Inc. Common Stock
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company.
2BB score and signals
Kenvue Inc. Common Stock’s current 2BB score is 28 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 60 | Strong |
| Quality | 100 | Very Strong |
| Risk | 32 | Low |
Company facts
| CEO | Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. |
| Headquarters | Summit, New Jersey, United States |
| Founded | Feb 23, 2022 |
| Employees | 21.9K |
| P/E ratio | 22.26 |
| 52-week range | $14.02 – $20.82 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-15 | — | 0.2721 | — | $3.95B |
| 2026-11-02 | — | 0.3008 | — | $3.94B |
| 2026-08-06 | — | 0.3256 | — | $4.05B |
| 2026-05-07 | 0.32 | 0.2675 | $3.91B | $3.92B |
Related companies
